세계의 식물성 원료의약품(API) 시장 규모, 점유율, 산업 동향 분석 리포트 : 최종 용도별, 분자 유형별, 지역별 전망과 예측(2023-2030년)

The Global Plant-based API Market size is expected to reach $42.6 billion by 2030, rising at a market growth of 5.8% CAGR during the forecast period.

The Plant-based API are majorly utilized in Pharmaceuticals to make a variety of medications and to provide a wide range of health advantages, therefore, the pharmaceutical sector registered $ 17,322.1 million revenue in the market in 2022. As chronic conditions like cancer, heart disease, and diabetes become more prevalent, there is an increasing demand for innovative and efficient therapies. The major causes of death in the United States, according to the CDC in 2022, were chronic diseases like diabetes, cancer, and heart disease. The country's $4.1 trillion in average healthcare costs per year are also largely attributable to them.

Similarly, according to the Australian Government, in 2020-21, one or more chronic illnesses were predicted to affect nearly half of Australians (11.6 million people or 47%). Therefore, the increasing chronic disease burden will aid in expanding the market. Some of the factors impacting the market are growing demand for sustainable and natural medicines, rise in healthcare industry investment levels, and issues like quality control, standardization, and sustainability of plant-based API.

Due to the rising consumer desire for sustainable and natural products, the demand for plant-based APIs is increasing. The environmental impact of what people use is becoming a growing concern for many customers, who are increasingly turning to sustainable and natural alternatives. As a result, numerous plant-based medications have been developed. One of the key factors boosting the market's growth is the increasing number and size of investments made in the healthcare industry by governments of different countries.

More emerging nations are anticipated to have expanded access to quality healthcare as a result of their explosive economic growth and rising healthcare costs. The market is growing as a result of rising healthcare industry spending. Many producers of APIs were returning to their pre-COVID initiatives, notably in the supply chain for vital medicines. Leading pharmaceutical companies are embracing new business models and providing solutions based on KPIs or key performance indicators per nation. Increased R&D in many nations resulted in the innovation of new APIs like plant-based. Therefore, the pandemic had a slightly positive impact on the market.

However, the regulatory environment surrounding plant-based APIs is unpredictable. A significant gap in fulfilling regulatory requirements for herbal medication research exacerbates the issue of herbal drug regulation. To establish the efficacy and safety of herbal medicines, there is inadequate scientific evidence. Hence, all these elements are hampering the growth of the market.

Molecule Type Outlook

Based on molecule type, the market is characterized into alkaloids, anthocyanin, flavonoids, phenolic acids, terpenoids, lignin & stilbenes, and others. The terpenoids segment procured a considerable growth rate in the market in 2022. The chemotherapeutic as well as therapeutic benefits of terpenoids are thought to be responsible for the segment's expansion. Terpenoids have been proven to have properties that make them beneficial in the prevention and treatment of a wide range of illnesses, including cancer. These properties include those that are antibacterial, antifungal, antiparasitic, antiallergenic, antiviral, immunomodulatory, antispasmodic, anti-inflammatory, and antihyperglycemic.

End Use Outlook

On the basis of end-use, the market is classified into pharmaceuticals, nutraceuticals, herbal based industries, and others. The pharmaceuticals segment recorded the largest revenue share in the market in 2022. The growth of the segment may be due to the rising incidence of chronic diseases and the market's growing need for cutting-edge treatments. The use of genetically engineered crops to produce drugs and vaccines, which helps provide medications at a reduced cost, is one of the significant advancements. As important stakeholders in the supply & distribution of such pharmaceuticals place a greater emphasis on them, the potential for plant-based pharmaceuticals to give patients speedier access to drugs is also expected to grow.

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered the maximum revenue share in the market in 2022. The increase in the geriatric population and the increased health consciousness among the populace are both credited with the market expansion in this region. According to the United States Census Bureau, in 2020, there were 55.8 million people over the age of one in the United States or 16.8% of the total population. Due to the widespread belief that nutraceuticals can prevent chronic diseases, the region exhibits strong adoption and consumption rates. Slowing down the aging process helps to promote health and prevent chronic diseases.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BASF SE, Evonik Industries AG (RAG-Stiftung), Cargill, Incorporated, Roquette Freres SA, Arboris, LLC, Centroflora Group, Kothari Phytochemicals & Industries Ltd., Brains Bioceutical Corp., Indo Phytochem Pharmaceuticals and HimPharm.

Scope of the Study

Market Segments covered in the Report:

By End-use

• Pharmaceuticals
• Nutraceuticals
• Herbal Based Industries & Others

By Molecule Type

• Alkaloids
• Anthocyanin
• Flavonoids
• Phenolic Acids
• Lignin & Stilbenes
• Terpenoids
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• BASF SE
• Evonik Industries AG (RAG-Stiftung)
• Cargill, Incorporated
• Roquette Freres SA
• Arboris, LLC
• Centroflora Group
• Kothari Phytochemicals & Industries Ltd.
• Brains Bioceutical Corp.
• Indo Phytochem Pharmaceuticals.
• HimPharm

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Plant-based API Market, by End-use
  • 1.4.2 Global Plant-based API Market, by Molecule Type
  • 1.4.3 Global Plant-based API Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market Composition and Scenario
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Global Plant-based API Market by End-use

• 3.1 Global Pharmaceuticals Market by Region
• 3.2 Global Nutraceuticals Market by Region
• 3.3 Global Herbal Based Industries & Others Market by Region

Chapter 4. Global Plant-based API Market by Molecule Type

• 4.1 Global Alkaloids Market by Region
• 4.2 Global Anthocyanin Market by Region
• 4.3 Global Flavonoids Market by Region
• 4.4 Global Phenolic Acids Market by Region
• 4.5 Global Lignin & Stilbenes Market by Region
• 4.6 Global Terpenoids Market by Region
• 4.7 Global Others Market by Region

Chapter 5. Global Plant-based API Market by Region

• 5.1 North America Plant-based API Market
  • 5.1.1 North America Plant-based API Market by End-use
    • 5.1.1.1 North America Pharmaceuticals Market by Country
    • 5.1.1.2 North America Nutraceuticals Market by Country
    • 5.1.1.3 North America Herbal Based Industries & Others Market by Country
  • 5.1.2 North America Plant-based API Market by Molecule Type
    • 5.1.2.1 North America Alkaloids Market by Country
    • 5.1.2.2 North America Anthocyanin Market by Country
    • 5.1.2.3 North America Flavonoids Market by Country
    • 5.1.2.4 North America Phenolic Acids Market by Country
    • 5.1.2.5 North America Lignin & Stilbenes Market by Country
    • 5.1.2.6 North America Terpenoids Market by Country
    • 5.1.2.7 North America Others Market by Country
  • 5.1.3 North America Plant-based API Market by Country
    • 5.1.3.1 US Plant-based API Market
      • 5.1.3.1.1 US Plant-based API Market by End-use
      • 5.1.3.1.2 US Plant-based API Market by Molecule Type
    • 5.1.3.2 Canada Plant-based API Market
      • 5.1.3.2.1 Canada Plant-based API Market by End-use
      • 5.1.3.2.2 Canada Plant-based API Market by Molecule Type
    • 5.1.3.3 Mexico Plant-based API Market
      • 5.1.3.3.1 Mexico Plant-based API Market by End-use
      • 5.1.3.3.2 Mexico Plant-based API Market by Molecule Type
    • 5.1.3.4 Rest of North America Plant-based API Market
      • 5.1.3.4.1 Rest of North America Plant-based API Market by End-use
      • 5.1.3.4.2 Rest of North America Plant-based API Market by Molecule Type
• 5.2 Europe Plant-based API Market
  • 5.2.1 Europe Plant-based API Market by End-use
    • 5.2.1.1 Europe Pharmaceuticals Market by Country
    • 5.2.1.2 Europe Nutraceuticals Market by Country
    • 5.2.1.3 Europe Herbal Based Industries & Others Market by Country
  • 5.2.2 Europe Plant-based API Market by Molecule Type
    • 5.2.2.1 Europe Alkaloids Market by Country
    • 5.2.2.2 Europe Anthocyanin Market by Country
    • 5.2.2.3 Europe Flavonoids Market by Country
    • 5.2.2.4 Europe Phenolic Acids Market by Country
    • 5.2.2.5 Europe Lignin & Stilbenes Market by Country
    • 5.2.2.6 Europe Terpenoids Market by Country
    • 5.2.2.7 Europe Others Market by Country
  • 5.2.3 Europe Plant-based API Market by Country
    • 5.2.3.1 Germany Plant-based API Market
      • 5.2.3.1.1 Germany Plant-based API Market by End-use
      • 5.2.3.1.2 Germany Plant-based API Market by Molecule Type
    • 5.2.3.2 UK Plant-based API Market
      • 5.2.3.2.1 UK Plant-based API Market by End-use
      • 5.2.3.2.2 UK Plant-based API Market by Molecule Type
    • 5.2.3.3 France Plant-based API Market
      • 5.2.3.3.1 France Plant-based API Market by End-use
      • 5.2.3.3.2 France Plant-based API Market by Molecule Type
    • 5.2.3.4 Russia Plant-based API Market
      • 5.2.3.4.1 Russia Plant-based API Market by End-use
      • 5.2.3.4.2 Russia Plant-based API Market by Molecule Type
    • 5.2.3.5 Spain Plant-based API Market
      • 5.2.3.5.1 Spain Plant-based API Market by End-use
      • 5.2.3.5.2 Spain Plant-based API Market by Molecule Type
    • 5.2.3.6 Italy Plant-based API Market
      • 5.2.3.6.1 Italy Plant-based API Market by End-use
      • 5.2.3.6.2 Italy Plant-based API Market by Molecule Type
    • 5.2.3.7 Rest of Europe Plant-based API Market
      • 5.2.3.7.1 Rest of Europe Plant-based API Market by End-use
      • 5.2.3.7.2 Rest of Europe Plant-based API Market by Molecule Type
• 5.3 Asia Pacific Plant-based API Market
  • 5.3.1 Asia Pacific Plant-based API Market by End-use
    • 5.3.1.1 Asia Pacific Pharmaceuticals Market by Country
    • 5.3.1.2 Asia Pacific Nutraceuticals Market by Country
    • 5.3.1.3 Asia Pacific Herbal Based Industries & Others Market by Country
  • 5.3.2 Asia Pacific Plant-based API Market by Molecule Type
    • 5.3.2.1 Asia Pacific Alkaloids Market by Country
    • 5.3.2.2 Asia Pacific Anthocyanin Market by Country
    • 5.3.2.3 Asia Pacific Flavonoids Market by Country
    • 5.3.2.4 Asia Pacific Phenolic Acids Market by Country
    • 5.3.2.5 Asia Pacific Lignin & Stilbenes Market by Country
    • 5.3.2.6 Asia Pacific Terpenoids Market by Country
    • 5.3.2.7 Asia Pacific Others Market by Country
  • 5.3.3 Asia Pacific Plant-based API Market by Country
    • 5.3.3.1 China Plant-based API Market
      • 5.3.3.1.1 China Plant-based API Market by End-use
      • 5.3.3.1.2 China Plant-based API Market by Molecule Type
    • 5.3.3.2 Japan Plant-based API Market
      • 5.3.3.2.1 Japan Plant-based API Market by End-use
      • 5.3.3.2.2 Japan Plant-based API Market by Molecule Type
    • 5.3.3.3 India Plant-based API Market
      • 5.3.3.3.1 India Plant-based API Market by End-use
      • 5.3.3.3.2 India Plant-based API Market by Molecule Type
    • 5.3.3.4 South Korea Plant-based API Market
      • 5.3.3.4.1 South Korea Plant-based API Market by End-use
      • 5.3.3.4.2 South Korea Plant-based API Market by Molecule Type
    • 5.3.3.5 Singapore Plant-based API Market
      • 5.3.3.5.1 Singapore Plant-based API Market by End-use
      • 5.3.3.5.2 Singapore Plant-based API Market by Molecule Type
    • 5.3.3.6 Malaysia Plant-based API Market
      • 5.3.3.6.1 Malaysia Plant-based API Market by End-use
      • 5.3.3.6.2 Malaysia Plant-based API Market by Molecule Type
    • 5.3.3.7 Rest of Asia Pacific Plant-based API Market
      • 5.3.3.7.1 Rest of Asia Pacific Plant-based API Market by End-use
      • 5.3.3.7.2 Rest of Asia Pacific Plant-based API Market by Molecule Type
• 5.4 LAMEA Plant-based API Market
  • 5.4.1 LAMEA Plant-based API Market by End-use
    • 5.4.1.1 LAMEA Pharmaceuticals Market by Country
    • 5.4.1.2 LAMEA Nutraceuticals Market by Country
    • 5.4.1.3 LAMEA Herbal Based Industries & Others Market by Country
  • 5.4.2 LAMEA Plant-based API Market by Molecule Type
    • 5.4.2.1 LAMEA Alkaloids Market by Country
    • 5.4.2.2 LAMEA Anthocyanin Market by Country
    • 5.4.2.3 LAMEA Flavonoids Market by Country
    • 5.4.2.4 LAMEA Phenolic Acids Market by Country
    • 5.4.2.5 LAMEA Lignin & Stilbenes Market by Country
    • 5.4.2.6 LAMEA Terpenoids Market by Country
    • 5.4.2.7 LAMEA Others Market by Country
  • 5.4.3 LAMEA Plant-based API Market by Country
    • 5.4.3.1 Brazil Plant-based API Market
      • 5.4.3.1.1 Brazil Plant-based API Market by End-use
      • 5.4.3.1.2 Brazil Plant-based API Market by Molecule Type
    • 5.4.3.2 Argentina Plant-based API Market
      • 5.4.3.2.1 Argentina Plant-based API Market by End-use
      • 5.4.3.2.2 Argentina Plant-based API Market by Molecule Type
    • 5.4.3.3 UAE Plant-based API Market
      • 5.4.3.3.1 UAE Plant-based API Market by End-use
      • 5.4.3.3.2 UAE Plant-based API Market by Molecule Type
    • 5.4.3.4 Saudi Arabia Plant-based API Market
      • 5.4.3.4.1 Saudi Arabia Plant-based API Market by End-use
      • 5.4.3.4.2 Saudi Arabia Plant-based API Market by Molecule Type
    • 5.4.3.5 South Africa Plant-based API Market
      • 5.4.3.5.1 South Africa Plant-based API Market by End-use
      • 5.4.3.5.2 South Africa Plant-based API Market by Molecule Type
    • 5.4.3.6 Nigeria Plant-based API Market
      • 5.4.3.6.1 Nigeria Plant-based API Market by End-use
      • 5.4.3.6.2 Nigeria Plant-based API Market by Molecule Type
    • 5.4.3.7 Rest of LAMEA Plant-based API Market
      • 5.4.3.7.1 Rest of LAMEA Plant-based API Market by End-use
      • 5.4.3.7.2 Rest of LAMEA Plant-based API Market by Molecule Type

Chapter 6. Company Profiles

• 6.1 BASF SE
  • 6.1.1 Company Overview
  • 6.1.2 Financial Analysis
  • 6.1.3 Segmental and Regional Analysis
  • 6.1.4 Research & Development Expense
  • 6.1.5 SWOT Analysis
• 6.2 Cargill, Incorporated
  • 6.2.1 Company Overview
• 6.3 Evonik Industries AG (RAG-Stiftung)
  • 6.3.1 Company Overview
  • 6.3.2 Financial Analysis
  • 6.3.3 Segmental and Regional Analysis
  • 6.3.4 Research & Development Expenses
  • 6.3.5 Recent strategies and developments:
    • 6.3.5.1 Product Launches and Product Expansions:
    • 6.3.5.2 Acquisition and Mergers:
• 6.4 Roquette Freres SA
  • 6.4.1 Company Overview
• 6.5 Arboris, LLC
  • 6.5.1 Company Overview
• 6.6 Centroflora Group
  • 6.6.1 Company Overview
• 6.7 Kothari Phytochemicals & Industries Ltd.
  • 6.7.1 Company Overview
  • 6.7.2 Financial Analysis
  • 6.7.3 Segmental and Regional Analysis
• 6.8 Brains Bioceutical Corp.
  • 6.8.1 Company Overview
• 6.9 Indo Phytochem Pharmaceuticals
  • 6.9.1 Company Overview
• 6.10. HimPharm
  • 6.10.1 Company Overview